InsiderTrades.com logo
Elon Musk has put himself in their crosshairs
From Porter & Company   |   Ad
Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.
I share with you in this special investigative documentary.

PTGX Insider Trading

Insider Ownership Percentage: 5.40%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $5,501,869.23

Protagonist Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Protagonist Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Protagonist Therapeutics Share Price & Price History

Current Price: $41.04
Price Change: ▼ Price Decrease of -1.63 (-3.82%)
As of 11/14/2024 05:40 PM ET

This chart shows the closing price history over time for PTGX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Elon Musk has put himself in their crosshairs
From Porter & Company   |   Ad
Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.
I share with you in this special investigative documentary.

Protagonist Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/11/2024Asif AliCFOSell14,203$44.49$631,891.4734,960View SEC Filing Icon  
9/10/2024William D. WaddillDirectorSell8,000$45.00$360,000.0012,000View SEC Filing Icon  
7/24/2024William D. WaddillDirectorSell8,000$40.00$320,000.0012,000View SEC Filing Icon  
6/7/2024Dinsesh V. PatelCEOSell35,000$35.19$1,231,650.00515,415View SEC Filing Icon  
6/7/2024William D. WaddillDirectorSell8,000$35.00$280,000.0012,000View SEC Filing Icon  
4/18/2024Asif AliCFOSell1,234$25.11$30,985.7437,163View SEC Filing Icon  
4/1/2024Dinsesh V. PatelCEOSell25,000$28.31$707,750.00549,590View SEC Filing Icon  
3/1/2024Asif AliCFOSell14,248$32.24$459,355.5238,397View SEC Filing Icon  
3/1/2024Dinsesh V. PatelCEOSell30,000$31.62$948,600.00574,590View SEC Filing Icon  
3/1/2024William D. WaddillDirectorSell12,975$31.34$406,636.5012,000View SEC Filing Icon  
1/9/2024Suneel GuptaInsiderSell5,000$25.00$125,000.00187,567View SEC Filing Icon  
12/21/2021Dinsesh V. PatelCEOSell15,000$32.14$482,100.00View SEC Filing Icon  
See Full Table
Elon Musk has put himself in their crosshairs
From Porter & Company   |   Ad
Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.
I share with you in this special investigative documentary.

SEC Filings (Institutional Ownership Changes) for Protagonist Therapeutics (NASDAQ:PTGX)

98.63% of Protagonist Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PTGX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Protagonist Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/14/2024Walleye Capital LLC105,335$4.74M0.0%N/A0.177%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC368,132$16.57M0.0%-0.5%0.618%Search for SEC Filing on Google Icon
11/14/2024Public Sector Pension Investment Board124,949$5.62M0.0%N/A0.210%Search for SEC Filing on Google Icon
11/13/2024Glenmede Trust Co. NA14,981$0.67M0.0%-3.4%0.025%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets20,294$0.91M0.0%+448.9%0.034%Search for SEC Filing on Google Icon
11/13/2024FMR LLC454,196$20.44M0.0%+4.5%0.762%Search for SEC Filing on Google Icon
11/13/2024Advantage Alpha Capital Partners LP11,336$0.51M0.1%N/A0.019%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company 115,765$5.21M0.0%+1.2%0.194%Search for SEC Filing on Google Icon
11/13/2024Harvest Fund Management Co. Ltd1,544$69K0.0%N/A0.003%Search for SEC Filing on Google Icon
11/12/2024Swedbank AB50,000$2.25M0.0%N/A0.085%Search for SEC Filing on Google Icon
11/12/2024Algert Global LLC115,679$5.21M0.1%-23.9%0.196%Search for SEC Filing on Google Icon
11/12/2024Cerity Partners LLC14,241$0.64M0.0%+26.7%0.024%Search for SEC Filing on Google Icon
11/12/2024Eagle Asset Management Inc.294,280$13.61M0.1%-17.7%0.500%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.565,503$25.45M0.0%+7.6%0.960%Search for SEC Filing on Google Icon
11/12/2024Pacer Advisors Inc.1,734,090$78.03M0.2%+405,061.2%2.944%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC19,128$0.86M0.0%N/A0.032%Search for SEC Filing on Google Icon
11/8/2024BNP PARIBAS ASSET MANAGEMENT Holding S.A.125,898$5.67M0.0%N/A0.214%Search for SEC Filing on Google Icon
11/8/2024Moran Wealth Management LLC15,030$0.68M0.0%+27.6%0.026%Search for SEC Filing on Google Icon
11/8/2024Segall Bryant & Hamill LLC120,301$5.41M0.1%+1.5%0.204%Search for SEC Filing on Google Icon
11/7/2024Quest Partners LLC23,947$1.08M0.1%+885.1%0.041%Search for SEC Filing on Google Icon
11/7/2024Thrivent Financial for Lutherans46,257$2.08M0.0%N/A0.079%Search for SEC Filing on Google Icon
11/6/2024Mutual of America Capital Management LLC8,860$0.40M0.0%N/A0.015%Search for SEC Filing on Google Icon
11/6/2024King Wealth Management Group6,000$0.27M0.0%-50.0%0.010%Search for SEC Filing on Google Icon
11/5/2024Victory Capital Management Inc.130,797$5.89M0.0%+1,729.3%0.222%Search for SEC Filing on Google Icon
11/5/2024Entropy Technologies LP6,929$0.31M0.0%N/A0.012%Search for SEC Filing on Google Icon
11/4/2024Los Angeles Capital Management LLC22,446$1.01M0.0%-27.2%0.038%Search for SEC Filing on Google Icon
10/31/2024Financial Enhancement Group LLC41,818$1.88M0.3%N/A0.071%Search for SEC Filing on Google Icon
10/30/2024Amalgamated Bank17,324$0.78M0.0%+756.4%0.030%Search for SEC Filing on Google Icon
10/29/2024Janney Montgomery Scott LLC19,249$0.87M0.0%N/A0.033%Search for SEC Filing on Google Icon
10/28/2024US Bancorp DE7,866$0.35M0.0%-8.2%0.013%Search for SEC Filing on Google Icon
10/28/2024Palumbo Wealth Management LLC5,211$0.23M0.1%N/A0.009%Search for SEC Filing on Google Icon
10/25/2024New York State Teachers Retirement System24,592$1.11M0.0%N/A0.042%Search for SEC Filing on Google Icon
10/25/2024China Universal Asset Management Co. Ltd.11,329$0.51M0.1%+64.4%0.019%Search for SEC Filing on Google Icon
10/24/2024Cavalier Investments LLC29,956$1.35M0.4%N/A0.051%Search for SEC Filing on Google Icon
10/24/2024State of Alaska Department of Revenue33,615$1.51M0.0%N/A0.057%Search for SEC Filing on Google Icon
10/23/2024Mirae Asset Global Investments Co. Ltd.2,130$95K0.0%+21.6%0.004%Search for SEC Filing on Google Icon
10/23/2024Louisiana State Employees Retirement System28,500$1.28M0.0%N/A0.048%Search for SEC Filing on Google Icon
10/23/2024Moody Aldrich Partners LLC119,287$5.37M1.0%-11.1%0.203%Search for SEC Filing on Google Icon
10/23/2024Hennion & Walsh Asset Management Inc.37,413$1.68M0.1%-1.2%0.064%Search for SEC Filing on Google Icon
10/21/2024Everence Capital Management Inc.7,050$0.32M0.0%N/A0.012%Search for SEC Filing on Google Icon
10/19/2024Allspring Global Investments Holdings LLC103,842$4.67M0.0%+24,162.1%0.176%Search for SEC Filing on Google Icon
10/16/2024Bleakley Financial Group LLC7,031$0.32M0.0%N/A0.012%Search for SEC Filing on Google Icon
10/15/2024Swedbank AB50,000$2.25M0.0%N/A0.085%Search for SEC Filing on Google Icon
10/11/2024Creative Planning7,504$0.34M0.0%N/A0.013%Search for SEC Filing on Google Icon
10/10/2024Exchange Traded Concepts LLC961$43K0.0%N/A0.002%Search for SEC Filing on Google Icon
10/10/2024Inspire Investing LLC36,514$1.64M0.2%+256.8%0.062%Search for SEC Filing on Google Icon
10/8/2024CWM LLC1,273$57K0.0%+910.3%0.002%Search for SEC Filing on Google Icon
10/7/2024GAMMA Investing LLC552$25K0.0%+749.2%0.001%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC25,740$1.16M0.0%+135.0%0.044%Search for SEC Filing on Google Icon
9/16/2024Point72 DIFC Ltd4,415$0.15M0.0%N/A0.007%Search for SEC Filing on Google Icon
9/16/2024Cubist Systematic Strategies LLC84,202$2.92M0.0%+1,304.5%0.143%Search for SEC Filing on Google Icon
8/16/2024Perceptive Advisors LLC1,268,735$43.96M1.0%+27.6%2.154%Search for SEC Filing on Google Icon
8/16/2024Northwestern Mutual Wealth Management Co.157,788$5.47M0.0%N/A0.268%Search for SEC Filing on Google Icon
8/16/2024Algert Global LLC152,079$5.27M0.2%+2.9%0.258%Search for SEC Filing on Google Icon
8/16/2024Driehaus Capital Management LLC556,835$19.29M0.2%-0.7%0.945%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company114,406$3.96M0.0%+27.6%0.194%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC958,283$33.21M0.0%+2,135.6%1.627%Search for SEC Filing on Google Icon
8/15/2024Dark Forest Capital Management LP60,962$2.11M0.4%N/A0.104%Search for SEC Filing on Google Icon
8/15/2024AQR Capital Management LLC25,055$0.87M0.0%-69.1%0.043%Search for SEC Filing on Google Icon
8/15/2024Point72 Asia Singapore Pte. Ltd.14,556$0.50M0.1%N/A0.025%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC9,823$0.34M0.0%N/A0.017%Search for SEC Filing on Google Icon
8/14/2024Point72 Asset Management L.P.909,734$31.52M0.1%-24.2%1.545%Search for SEC Filing on Google Icon
8/14/2024Cubist Systematic Strategies LLC84,202$2.92M0.0%+1,304.5%0.143%Search for SEC Filing on Google Icon
8/14/2024Point72 DIFC Ltd4,415$0.15M0.0%N/A0.007%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP572,177$19.83M0.0%-41.4%0.971%Search for SEC Filing on Google Icon
8/14/2024Farallon Capital Management LLC5,840,773$202.38M1.0%+1.8%9.916%Search for SEC Filing on Google Icon
8/14/2024ProShare Advisors LLC11,270$0.39M0.0%-21.4%0.019%Search for SEC Filing on Google Icon
8/14/2024Profund Advisors LLC14,529$0.50M0.0%-61.2%0.025%Search for SEC Filing on Google Icon
8/12/2024Inspire Investing LLC10,234$0.36M0.0%-17.1%0.017%Search for SEC Filing on Google Icon
8/12/2024Seven Eight Capital LP36,793$1.28M0.1%+426.9%0.063%Search for SEC Filing on Google Icon
8/12/2024Hsbc Holdings PLC7,529$0.26M0.0%-93.3%0.013%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC297,467$10.31M0.0%+813.4%0.507%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP616,172$21.35M0.0%-22.1%1.051%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.27,311$0.95M0.0%-83.0%0.047%Search for SEC Filing on Google Icon
8/7/2024Cowen AND Company LLC1,182,268$40.97M1.1%-24.1%2.016%Search for SEC Filing on Google Icon
8/6/2024Quest Partners LLC2,431$84K0.0%-58.8%0.004%Search for SEC Filing on Google Icon
8/6/2024Great Lakes Advisors LLC93,479$3.24M0.0%-3.8%0.159%Search for SEC Filing on Google Icon
8/6/2024Candriam S.C.A.273,818$9.49M0.1%-23.9%0.467%Search for SEC Filing on Google Icon
8/5/2024Arizona State Retirement System12,236$0.42M0.0%-3.5%0.021%Search for SEC Filing on Google Icon
8/3/2024TD Asset Management Inc148,302$5.14M0.0%+36.7%0.253%Search for SEC Filing on Google Icon
8/2/2024Cannon Global Investment Management LLC69,900$2.42M11.2%N/A0.119%Search for SEC Filing on Google Icon
7/29/2024Principal Financial Group Inc.10,028$0.35M0.0%-30.2%0.017%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp204,299$7.08M0.0%+9.1%0.348%Search for SEC Filing on Google Icon
7/20/2024Hennion & Walsh Asset Management Inc.37,880$1.31M0.1%+8.6%0.065%Search for SEC Filing on Google Icon
7/12/2024SG Americas Securities LLC10,951$0.38M0.0%N/A0.019%Search for SEC Filing on Google Icon
5/24/2024Farallon Capital Management LLC5,738,973$166.03M0.7%+0.1%9.785%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System47,239$1.37M0.0%-6.3%0.081%Search for SEC Filing on Google Icon
5/16/2024Kennedy Capital Management LLC298,068$8.62M0.2%-2.2%0.508%Search for SEC Filing on Google Icon
5/16/2024Kynam Capital Management LP1,144,242$33.10M3.5%-42.9%1.951%Search for SEC Filing on Google Icon
5/16/2024BVF Inc. IL3,755,990$108.66M3.0%-34.6%6.404%Search for SEC Filing on Google Icon
5/16/2024Silvercrest Asset Management Group LLC188,743$5.46M0.0%+4.6%0.322%Search for SEC Filing on Google Icon
5/16/2024Caxton Associates LP16,047$0.46M0.0%N/A0.027%Search for SEC Filing on Google Icon
5/15/2024Bellevue Group AG19,146$0.55M0.0%-36.2%0.033%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD819,296$23.70M0.0%-0.5%1.397%Search for SEC Filing on Google Icon
5/15/2024Lazard Asset Management LLC2,415$69K0.0%N/A0.004%Search for SEC Filing on Google Icon
5/15/2024Affinity Asset Advisors LLC100,000$2.89M0.4%N/A0.170%Search for SEC Filing on Google Icon
5/14/2024CANADA LIFE ASSURANCE Co9,083$0.26M0.0%+74.2%0.015%Search for SEC Filing on Google Icon
5/13/2024Seven Eight Capital LP6,983$0.20M0.0%N/A0.012%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.3,192,971$92.37M0.0%+1.2%5.445%Search for SEC Filing on Google Icon
5/9/2024State Board of Administration of Florida Retirement System11,323$0.33M0.0%-30.5%0.019%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Protagonist Therapeutics logo
Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide-based drugs for hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing Rusfertide (PTG-300), an injectable hepcidin mimetic that completed phase 2 clinical trials for the treatment of polycythemia vera and other blood disorders; and JNJ-2113, an orally delivered investigational drug to block biological pathways that completed phase 2b clinical trials for the treatment of moderate-to-severe plaque psoriasis; and PN-943, an orally delivered, gut-restricted alpha 4 beta 7 specific integrin antagonist completed a phase 2 clinical trials in patients with moderate to severe ulcerative colitis. The company has a license and collaboration agreement with Takeda to commercialize rusfertide; and JNJ Innovative Medicines to co-develop Interleukin-23 receptor antagonist compound JNJ-2113. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.
Read More on Protagonist Therapeutics

Today's Range

Now: $41.04
Low: $40.91
High: $43.14

50 Day Range

MA: $45.66
Low: $41.50
High: $48.43

52 Week Range

Now: $41.04
Low: $15.58
High: $48.89

Volume

617,717 shs

Average Volume

733,127 shs

Market Capitalization

$2.45 billion

P/E Ratio

15.43

Dividend Yield

N/A

Beta

2.17

Who are the company insiders with the largest holdings of Protagonist Therapeutics?

Protagonist Therapeutics' top insider investors include:
  1. Dinesh V Ph D Patel (CEO)
  2. Suneel Gupta (Insider)
  3. Asif Ali (CFO)
  4. William D Waddill (Director)
Learn More about top insider investors at Protagonist Therapeutics.

Who are the major institutional investors of Protagonist Therapeutics?

Protagonist Therapeutics' top institutional shareholders include:
  1. Pacer Advisors Inc. — 2.94%
  2. Charles Schwab Investment Management Inc. — 0.96%
  3. FMR LLC — 0.76%
  4. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC — 0.62%
  5. Eagle Asset Management Inc. — 0.50%
  6. Victory Capital Management Inc. — 0.22%
Learn More about top institutional investors of Protagonist Therapeutics stock.

Which major investors are selling Protagonist Therapeutics stock?

Within the previous quarter, PTGX stock was sold by these institutional investors:
  1. Eagle Asset Management Inc.
  2. Algert Global LLC
  3. Moody Aldrich Partners LLC
  4. Los Angeles Capital Management LLC
  5. King Wealth Management Group
  6. Belvedere Trading LLC
  7. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
  8. US Bancorp DE
During the previous year, company insiders that have sold Protagonist Therapeutics company stock include:
  1. Dinesh V Ph D Patel (CEO)
  2. Suneel Gupta (Insider)
  3. Asif Ali (CFO)
  4. William D Waddill (Director)
Learn More investors selling Protagonist Therapeutics stock.

Which major investors are buying Protagonist Therapeutics stock?

Within the last quarter, PTGX stock was bought by institutional investors including:
  1. Pacer Advisors Inc.
  2. BNP PARIBAS ASSET MANAGEMENT Holding S.A.
  3. Public Sector Pension Investment Board
  4. Victory Capital Management Inc.
  5. Walleye Capital LLC
  6. Allspring Global Investments Holdings LLC
  7. Swedbank AB
  8. Swedbank AB
Elon Musk has put himself in their crosshairs
From Porter & Company   |   Ad
Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.
I share with you in this special investigative documentary.